MoonLake Immunotherapeutics CSO Kristian Reich disposes of $1 million in common shares
MLTX•Kristian Reich sells MoonLake shares
MoonLake Immunotherapeutics Chief Scientific Officer Kristian Reich sold 52,448 Class A ordinary shares on July 21-22.
- Sales were priced at $20.02 per share on 50,000 shares and $20 per share on 2,448 shares.
- Indirect holdings fell to 2,712,298 shares following the transactions.
- Separately, he reported 35,389 shares held directly.
